Joint Formulary & PAD

Itulazax (birch pollen) - Allergen immunotherapy

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Oral lyophilisates
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important

Ituluzax (birch pollen) - RSFT Immunology only. Approved for over 18s only

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Itulazax (birch pollen)
Indication :
Allergen immunotherapy
Group Name :
Keywords :
Brand Names Include :
Itulazax
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Itulazax (birch pollen) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Allergen immunotherapy.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.